Dianthus Therapeutics | MGTA - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Celltrion KRW 621.35M 55.31M 2025-12
Dianthus Therapeutics USD 3.66M 255K 2025-09
IQVIA Holdings USD 10M 1000K 2026-03
Kangmei Pharma CNY 2.44M 635.78K 2026-03
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma EUR 139K 42K 2025-06
Medical Developments International AUD 174K 31K 2024-12
Moderna USD 70M 3M 2025-12
Pharma Mar EUR 1.63M 3.17M 2025-12
Qiagen NV USD 20M 4.93M 2025-12
Revvity USD 5.75M 5.75M 2025-12
Sartorius EUR -31.8M 86.7M 2025-12
Tectonic Therapeutic USD 1.74M 217K 2024-12
Tilray USD 12.83M 20.19M 2024-05
Xeris Pharmaceuticals USD 1.16M 210K 2025-09
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M 2026-03